Extracorporeal Membrane Oxygenation Machine Market Size Worth $394.9 Million By 2027

The global extracorporeal membrane oxygenation machine market size is expected to reach USD 394.9 million by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 4.5% over the forecast period. The market is primarily driven by increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of extracorporeal membrane oxygenation (ECMO) procedures. Cardiovascular disease is one of the leading causes of death globally. According to WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Increasing awareness about ECMO procedures, coupled with various government initiatives, are further propelling the market for extracorporeal membrane oxygenation machines.

Increasing survival rate of cardiac and respiratory patients undergoing ECMO machine-supported surgery is also driving the ECMO machine market. Application of extracorporeal membrane oxygenation machine in procedures has increased over the years. This machine was traditionally used in cases of circulatory or respiratory failure. However, its applications have expanded to be used as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure. The use of extracorporeal membrane oxygenation machines has been rising gradually worldwide owing to its benefits such as acting as an artificial lung for patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities are fueling the market for extracorporeal membrane oxygenation machines. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030, rising from USD 320 billion in 2011.

Full Research Report On Extracorporeal Membrane Oxygenation Machine Market Visit Here: https://www.grandviewresearch.com/industry-analysis/extracorporeal-membrane-oxygenation-ecmo-market

Further key findings from the report suggest:

• By component, the oxygenators segment accounted for the leading revenue share in 2019 owing to its high cost and usage
• Based on modality, veno-arterial ECMO machines held the dominant market share in 2019 and is also expected to register the fastest growth rate during the forecast period
• On the basis of patient type, the adult segment is likely to exhibit a rapid pace over the course of the forecast period owing to rising incidence of cardiac and pulmonary diseases
• The respiratory application segment emerged as the leading revenue contributor in the ECMO machine market in 2019 and is also expected to grow at the fastest rate
• North America accounted for the largest share in 2019 owing to favorable reimbursement policies, presence of key players, and government initiatives
• Leading players in the extracorporeal membrane oxygenation machines market include Nipro Medical Corporation Medtronic plc, Microport Scientific Corporation, Sorin Group, MAQUET Holding B.V. & Co. KG, Terumo Cardiovascular Systems Corporation, and Medos Medizintechnik AG. Major players are focusing on technological collaborations and product launches to stay ahead.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/extracorporeal-membrane-oxygenation-ecmo-market/request/rs1

Grand View Research has segmented the global extracorporeal membrane oxygenation machines market on the basis of component, modality, patient type, application, and region:

ECMO Machine Component Type (Revenue, USD Million, 2019 - 2027)

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories

ECMO Machine Modality Outlook (Revenue, USD Million, 2016 - 2027)

• Veno-arterial
• Veno-venous
• Arterio-venous

ECMO Machine Patient Type Outlook (Revenue, USD Million, 2016 - 2027)

• Neonates
• Pediatric
• Adult

ECMO Machine Application Outlook (Revenue, USD Million, 2016 - 2027)

• Respiratory
• Neonates
• Pediatric
• Adult
• Cardiac
• Neonates
• Pediatric
• Adult
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)
• Neonates
• Pediatric
• Adult

ECMO Machine Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Czech Republic
• Russia
• Poland
• Turkey
• Switzerland
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Vietnam
• Philippines
• Malaysia
• Indonesia
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Chile
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Oman
• Kuwait

About Grand View Research                        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Asthma Therapeutics Market Size Is Projected To Reach $25.6 Billion By 2024

Global asthma therapeutics market is expected to reach USD 25.6 billion by 2024, according to a new study by Grand View Research, Inc. 

The increasing prevalence of asthma coupled with the adoption of biologics as a long-term treatment option to treat the severe form of asthma is expected to offer this market with lucrative growth opportunities. According to the statistics published by the World Allergy Journal, in May 2014, patients suffering from asthma registered around 300 million and the number is expected to soar due to a large number of individuals inclining towards unhealthy dietary habits and sedentary lifestyles. 

In addition, patent expiration of branded drugs, such as Singulair, Advair and other major drugs during the forecast period has led to a stiff generic competition, which will negatively impact the asthma therapeutics market growth in the coming years. On the contrary, the introduction of biologics is accruing towards the increasing market share of the asthma therapeutics segment, and is anticipated to continue during the forecast period. 

The enhanced demand for personalized medicine approach as opposed to the conventional medication prescription pattern for treatment of severe asthma is anticipated to aid the emergence of asthma therapeutics market in the future. In addition, development of technologically advanced products, such as pressurized metered dose inhalers and smart inhalers, equipped with sensor technology and inbuilt wireless communication system is further expected to propel the asthma therapeutics market growth in the next seven years.  

Full Research Report On Asthma Therapeutics Market Visit Here: https://www.grandviewresearch.com/industry-analysis/asthma-therapeutics-market

Further key findings from the study suggest:

• The anti-inflammatory drug class is expected to exhibit rapid growth at a lucrative CAGR of 3.4% over the forecast period owing to the introduction of affordable and innovative biologics targeting the severe asthma condition. In addition, the awareness gained pertaining to the benefits rendered by the biologics and monoclonal antibodies is anticipated to exhibit an upward shift in the market expansion in the coming years.
• The dry powder inhalers (DPIs) are expected to be the fastest growing segment due to the increasing adoption of these devices because of their high clinical efficiency than other inhalers. They are able to deliver both, small and large-sized drug components and dispense specialty engineered molecules. These related merits have spiked the adoption rates thereby contributing towards the risen market penetration.
• Rising number of individuals opting for alternative treatment options, such as inhaled fixed-dose combination drugs for asthma medication is anticipated to serve this market with future growth opportunities. The inhalers market is expected to grow at a CAGR of above 2.0% over the forecast period. 

• Some of the key players operating in the asthma therapeutics market include AstraZeneca Plc, Philips Healthcare, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Roche Diagnostics, and Merck& Co., Inc. 

• Market leaders are focusing on the introduction of technologically advanced devices and novel, improved biologics to gain a competitive advantage. The asthma therapeutics segment has a very strong pipeline as there are almost 100 novel molecules that are in the development phase and manufacturers are focusing on the development of personalized medication. The aforementioned factors collectively strengthen the industry growth in the near future. 

• For instance, drug molecules, such as Cinquil by Teva Pharmaceutical Industries Ltd., Lebrikizumab by Roche (Phase III), Mastinib by AB Science (Phase II/III), and Bosatria by GlaxoSmithKline Plc (Phase III), are in the development stage undergoing clinical research trials. Their commercial availability during the forecast period is expected to provide a boost to this vertical.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/asthma-therapeutics-market/request/rs1

Grand View Research has segmented the global asthma therapeutics market on the basis of drug class, product, route of administration, and region: 

Global Asthma Therapeutics Drug Class Outlook (Revenue, USD Million, 2013 – 2024)

• Anti-inflammatory
• Bronchodilators
• Combination therapy

Global Asthma Therapeutics Product Outlook (Revenue, USD Million, 2013 – 2024)

• Inhalers
• Dry powder inhalers
• Metered dose inhalers
• Soft mist inhalers
• Nebulizers

Global Asthma Therapeutics Route of Administration Outlook (Revenue, USD Million, 2013 – 2024)

• Oral
• Inhaled
• Intravenous

Asthma Therapeutics Regional Outlook (Revenue, USD Million, 2013 – 2024)

• North America
• U.S.
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa

About Grand View Research                        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Vein Illuminator Market Size, Share, Revenue, Future Growth And Insights And Trends

The global vein illuminator market size is expected to reach USD 793.8 million by 2027, registering revenue based CAGR of 30.6% over the forecast period, according to a new report by Grand View Research, Inc. Growing demand for easy visualization of inaccessible veins in neonates, elderly, dark skinned, and obese patients is expected to aid the market growth. Moreover, growing need for intravenous drugs for the treatment of various disorders is anticipated to further propel the product demand.

As per the American Civil Liberties Union, 350,000 people in U.S. regularly use injectable drugs. The process requires proper knowledge regarding IV drugs in order to avoid infections that are caused due to injection drug use. Therefore, growing adoption of IV drugs for various purposes is expected to boost the adoption of vein illuminators for avoiding infections and enhancing proper treatment.

Growing demand for painless insertion in drawing blood or intravenous access is also expected to drive the market growth. These devices are mainly advantageous for the application in children and adults, as it reduces the risks of multiple needle pricks done to infants and old age patients. Illumination technology eases the job of clinicians by creating a road map of the main vein.

Rising prevalence of chronic diseases worldwide is increasing the demand for diagnosis and treatment, which in turn is expected to drive the market growth. According to recent studies, it is estimated that around 500 million venipuncture procedures are performed every year. Usage of vein illuminator increases the success rate of venipuncture and hence enhances the diagnosis and treatment.

Full Research Report On Vein Illuminator Market Visit Here: https://www.grandviewresearch.com/industry-analysis/vein-illuminator-market

Vein Illuminator Market Report Highlights

• Infrared technology held the largest revenue share in 2019 and is expected to grow at the fastest rate during the forecast period mainly due to its ability to illuminate veins located deep inside the tissue for proper intravenous access and blood draw
• Transillumination technology is also expected to experience a significant growth during the forecast period because it uses LED lights, which enhances the structure of the vein
• The intravenous access segment held the largest revenue share in 2019 and is expected to register the fastest growth rate largely due to increasing usage of intravenous drugs for treatment of various chronic diseases
• The usage of vein illuminators is also increasing mainly because of growing demand for diagnosing chronic diseases and for avoiding the after effects or infections of multiple needle pricks
• The hospitals segment held the largest revenue share and is expected to experience the fastest growth rate during the forecast period increasing adoption in hospitals for streamlining the IV procedures with comfort
• North America dominated the vein illuminator market with the largest revenue share in 2019 owing to the presence of major market players and increasing product launches in the region
• Asia Pacific is expected to grow at the fastest growth rate during the forecast period mainly due to growing healthcare expenditure in the region and growing strategic alliances between the global players for distribution in the region

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/vein-illuminator-market/request/rs1

Vein Illuminator Market Segmentation

Grand View Research has segmented the global vein illuminator market based on technology, application, end use, and region:

Vein Illuminator Technology Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)

• Transillumination
• Infrared
• Ultrasound

Vein Illuminator Application Outlook (Revenue, USD Million, 2016 - 2027)

• Intravenous Access
• Blood Draw
• Others

Vein Illuminator End-Use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Blood Donation Camps
• Academic Institutions
• Others

Vein Illuminator Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Netherlands
• Switzerland
• Turkey
• Poland
• Asia Pacific
• China
• Japan
• India
• Thailand
• South Korea
• Indonesia
• Taiwan
• Hong Kong
• Philippines
• Malaysia
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Chile
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Qatar

About Grand View Research                        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Parenteral Nutrition Market Size Is Predicted To Reach $8.26 Billion By 2026

The global parenteral nutrition market size is expected to reach USD 8.26 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.8% during the forecast period. Increasing rate of natality and surging geriatric population is fueling the market growth.

As of 2014, the natality rate reported by the National Center for Health Statistics (NCHS) is 12.5 births per 1,000 populations in U.S. Furthermore, the percentage of lower weight infants was 8.0%, thereby boosting the demand for parenteral nutrition products in the country.

The realized natality is rising over the last decade and is anticipated to sustain growth over the forecast period. However, in 2011, a dip was witnessed in U.S. owing to alteration in fertility rate of the local female population. However, in the same year, hike in the number of births for foreign based immigrant citizens was also observed leading to an overall rise in birth rate.

Moreover, a large number of premature babies suffer from low weight as well as undeveloped immunity thus putting them at risk. Parenteral nutrition reduces the risk of infection and underdevelopment, thereby promoting its application.

As per the National Center for Healthcare Statistics, the premature birth rate of the U.S. is about 9.6% as of 2016, and the national authorities are working to reduce it to 8.1%.

In very low birth weight (VLBW) newborns, demand for parenteral nutrition is higher owing to low prospect of enteral nutrition. Hence, use of parenteral nutrition in premature infants results in improved intrauterine nutrient deposition, faster neurological development, and minimized risk of complications thus improving their chances for survival. 

Full Research Report On Parenteral Nutrition Market Visit Here: https://www.grandviewresearch.com/industry-analysis/parenteral-nutrition-market

Further key findings from the study suggest:

• Single dose amino acid solution segment dominated the market in 2018 owing to increasing use of amino acid solutions that possess fewer side effects thus enhancing patient benefits
• North America led the market in terms of revenue and accounted for 41.73% of the overall share in 2018. Presence of high research expenditure by private entities and government agencies in the healthcare sector and collaborations among medical device industry, regulatory authorities, and universities are responsible for the market growth
• Some of the companies present in the parenteral nutrition market are B. Braun Melsungen AG; Baxter International, Inc.; Fresenius Kabi AG; Hospira, Inc.; Actavis, Inc.; Grifols International S.A.; Otsuka Pharmaceutical Factory, Inc.; and Sichuan Kelun Pharmaceutical Co. Ltd.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/parenteral-nutrition-market/request/rs1

Grand View Research has segmented the global parenteral nutrition market based on nutrient type and region:

Parenteral Nutrition Nutrient Type Outlook (Revenue, USD Million, 2015 - 2026)

• Carbohydrates
• Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins & Minerals

Parenteral Nutrition Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Spain
• Italy
• France
• Asia Pacific
• Japan
• China
• India
• Thailand
• South Korea
• Latin America
• Brazil
• Argentina
• Mexico
• Colombia
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE

About Grand View Research                        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com